Cronos Group Inc vs Gemini Space Station Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Gemini Space Station Inc trades at $4.43 (market cap $579.55M). The key difference: Cronos Group Inc is far larger — about 2× Gemini Space Station Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Gemini Space Station Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Gemini Space Station Inc for 14 Days on average.
| CRON | GEMI | |
|---|---|---|
Market Cap | $1.18B | $579.55M |
Volume | 968,037 | 1,882,406 |
Sector | Health | Financials |
52-Week High | $3.55 | $25.41 |
52-Week Low | $2.30 | $3.54 |
Typical Hold Time | 22 Days | 14 Days |
Enterprise Value | $387.62M | $558.57M |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% today amid a bearish technical signal. Recent quarterly earnings show beats in Q1 and Q2 2026, with revenue growth from $118M in 2024 to $147M in 2025. The company reported a net loss of $9.45M in 2025 but projects a profit of $70M for 2026. Analyst sentiment is mixed with a 20% buy rating. News highlights focus on international expansion and a recent Investor Day outlining growth strategies.
Outlook is cautiously optimistic given projected profitability in 2026 and strong cash reserves, but risks include sustained negative cash flow and competitive pressures. The stock's valuation metrics like P/E of 16.95 and P/S of 6.84 suggest moderate pricing relative to peers, though high EV/EBITDA of 43 indicates premium expectations.
Gemini Space Station (GEMI) trades at $4.43, down 1.34% on the day, with a bearish technical outlook despite recent price surges. The company reported Q2 2026 revenue growth of 37% year-over-year but continues to post significant losses, with a net income margin of -250.13%. Recent news highlights expansion into commission-free stock trading and prediction markets, though the stock faces headwinds from earnings misses and ongoing class action lawsuits.
The investment outlook remains high-risk due to persistent unprofitability and negative cash flow from operations. While analyst consensus suggests modest upside to a $5.25 price target, the stock's viability depends on achieving profitability amid competitive pressures and regulatory scrutiny. Current valuation metrics appear stretched given the company's fundamental challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →